The Board of Directors of Astec LifeSciences Limited has appointed Anurag Roy as the Chief Executive Officer (CEO) for a term of three years with effect from 28th July, 2021 upto 27th July, 2024.

Roy has also been appointed as an Additional Director and Whole Time Director for a term of 3 three years with effect from 28th July, 2021 upto 27th July, 2024 which is subject to approval of the shareholders of the company.

He has over 21 years’ experience working in leading pharmaceutical/chemical companies such as DSM, Dr. Reddy’s Labs, BASF, and Jubilant Life Sciences. He has a proven track record of delivering commercial and operational excellence and leading several manufacturing, supply sites and CMOs. He joins Astec LifeSciences Limited from Navin Fluorine International Ltd./Manchester Organics wherein he was working as COO - CRAMS, Pharmaceuticals. He was responsible for P&L to manage and grow the global contract development & manufacturing business with global footprints (UK, Japan, and USA) and GMP manufacturing in India.